IBER
Price:
$10.18
Market Cap:
$175.60M
Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.
Industry
Shell Companies
IPO Date
Stock Exchange
NYSE
Ticker
IBER
According to Ibere Pharmaceuticals’s latest financial reports and current stock price. The company's current ROE is 2.46%. This represents a change of -3.93% compared to the average of 2.56% of the last 4 quarters.
The mean historical ROE of Ibere Pharmaceuticals over the last ten years is 0.61%. The current 2.46% ROE has changed 299.94% with respect to the historical average. Over the past ten years (40 quarters), IBER's ROE was at its highest in in the March 2022 quarter at 5.70%. The ROE was at its lowest in in the June 2021 quarter at -0.09%.
Average
0.61%
Median
0.61%
Minimum
0%
Maximum
1.23%
Discovering the peaks and valleys of Ibere Pharmaceuticals ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual ROE = 1.23%
Minimum Annual Increase = 0%
Minimum Annual ROE = 0%
| Year | ROE | Change |
|---|---|---|
| 2021 | 1.23% | Infinity% |
The current ROE of Ibere Pharmaceuticals (IBER) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0.61%
5-year avg
0.61%
10-year avg
0.61%
Ibere Pharmaceuticals’s ROE is less than Parabellum Acquisition Corp. (4.55%), less than Enphys Acquisition Corp. (6.75%), greater than Slam Corp. (-32.15%), less than Bridgetown Holdings Limited (0%), less than Tristar Acquisition I Corp. (4.21%), less than Learn CW Investment Corporation (2.48%), greater than Vector Acquisition Corporation (-46.42%), less than AP Acquisition Corp. (2.41%), less than Fusion Acquisition Corp. II (0%),
| Company | ROE | Market cap |
|---|---|---|
| 4.55% | $178.79M | |
| 6.75% | $163.71M | |
| -32.15% | $261.27M | |
| 0% | $184.30M | |
| 4.21% | $187.64M | |
| 2.48% | $164.01M | |
| -46.42% | $5.53B | |
| 2.41% | $178.79M | |
| 0% | $178.07M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ibere Pharmaceuticals using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ibere Pharmaceuticals or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Ibere Pharmaceuticals's ROE?
How is the ROE calculated for Ibere Pharmaceuticals (IBER)?
What is the highest ROE for Ibere Pharmaceuticals (IBER)?
What is the 3-year average ROE for Ibere Pharmaceuticals (IBER)?
What is the 5-year average ROE for Ibere Pharmaceuticals (IBER)?
How does the current ROE for Ibere Pharmaceuticals (IBER) compare to its historical average?